Hsp90 inhibitors (Plex Pharmaceuticals)

N/A

Report date: 2025/01/26 19:26:19
NME

Base Information

Drug NameHsp90 inhibitors (Plex Pharmaceuticals)
Drug Alias NameHsp90 inhibitors (CalAsia)heat shock protein 90 inhibitors (CalAsia)heat shock protein 90 inhibitors (Plex Pharmaceuticals)Parkinson's disease therapy (CalAsia)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPlex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPlex Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A